Transcriptome profile of human neuroblastoma cells in the hypomagnetic field

Science China Life Sciences

Volumn 57, Issue 4, 2014, Pages 448-461

  Mo, WeiChuan ^a,b   Liu, Ying ^a   Bartlett, Perry F ^b   He, RongQiao ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CRY2; geomagnetic field; hypomagnetic field; MAPK1; massively parallel sequencing; transcriptome profile

Indexed keywords

CHROMATIN; RNA; TRANSCRIPTOME;

BRAIN; CHEMISTRY; CHROMATIN; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SEQUENCING; HUMAN; MAGNETIC FIELD; METABOLISM; MOLECULAR GENETICS; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; UPREGULATION;

BASE SEQUENCE; BRAIN; CELL LINE, TUMOR; CHROMATIN; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MAGNETIC FIELDS; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; RNA; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTOME; UP-REGULATION;

EID: 84899704190     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4644-z     Document Type: Review

References (78)

1. Wiltschko W, Wilschko R. Magnetic orientation and magnetor-eception in birds and other animals. J Comp Physiol A, 2005, 191: 675-693.
2. Lohmann KJ, Lohmann CMF, Putman NF. Magnetic maps in animals: nature's GPS. J Exp Biol, 2007, 210: 3697-3705.
3. Kopanev VI, Efimenko GD, Shakula AV. Biological effect of a hypogeomagnetic environment on an organism. Biol Bull Acad Sci USSR, 1979, 6: 289-298.
4. Dubrov AP. The Geomagnetic Field and Life: Geomagnetobiology. New York: Plenum, 1989. Chapter 4 (translated from Russian by Sinclair FL).
5. Mo WC, Liu Y, He RQ. A biological perspective of the hypomagnetic field: from definition towards mechanism. Prog Biochem Biophys, 2012, 39: 835-842.
6. Asashima M, Shimada K, Pfeiffer CJ. Magnetic shielding induces early developmental abnormalities in the newt, Cynops pyrrhogaster. Bioelectromagnetics, 1991, 12: 215-224.
7. Mo WC, Liu Y, Cooper HM, He RQ. Altered development of Xenopus embryos in a hypogeomagnetic field. Bioelectromagnetics, 2012, 33: 238-246.
8. Jiang JC, Jin HQ, Lin YF, Chen H, Yang XY, Zeng XP, Zhou X. Effect of magnetic free field space (MFFS) on vocal behavior in melop sittacus undulafus. Acta Seismol Sin, 1998, 20: 421-426.
9. Bliss VL, Heppner FH. Circadian activity rhythm influenced by near zero magnetic field. Nature, 1979, 261: 411-412.
10. Zamoshchina TA, Krivova NA, Khodanovich MIu, Trukhanov KA, Tukhvatulin RT, Zaeva OB, Zelenskaia AE, Gul' EV. Influence of simulated hypomagnetic environment in a far space flight on the rhythmic structure of rat's behavior (in Russian). Aviakosm Ekolog Med, 2012, 46: 17-23.
11. Zhang B, Lu H, Xi W, Zhou X, Xu S, Zhang K, Jiang J, Li Y, Guo A. Exposure to hypomagnetic field space for multiple generations causes amnesia in Drosophila melanogaster. Neurosci Lett, 2004, 371: 190-195.
12. Xu ML, Wang XB, Li B, Li DF, Jiang JC. Long-term memory was impaired in one-trial passive avoidance task of day-old chicks hatching from hypomagnetic field space. Chinese Sci Bull, 2003, 48: 2454-2457.
13. Xiao Y, Wang Q, Xu ML, Jiang JC, Li B. Chicks incubated in hypomagnetic field need more exogenous noradrenaline for memory consolidation. Adv Space Res, 2009, 44: 226-232.
14. Del Seppia C, Luschi P, Ghione S, Crosio E, Choleris E, Papi F. Exposure to a hypogeomagnetic field or to oscillating magnetic fields similarly reduce stress-induced analgesia in C57 male mice. Life Sci, 2000, 66: 1299-1306.
15. Choleris E, Del Seppia C, Thomas AW, Luschi P, Ghione G, Moran GR, Prato FS. Shielding, but not zeroing of the ambient magnetic field reduces stress-induced analgesia in mice. Proc Biol Sci, 2002, 269: 193-201.
16. Prato FS, Robertson JA, Desjardins D, Hensel J, Thomas AW. Daily repeated magnetic field shielding induces analgesia in CD-1 mice. Bioelectromagnetics, 2005, 26: 109-117.
17. Binhi VN, Sarimov RM. Zero magnetic field effect observed in human cognitive processes. Electromagn Biol Med, 2009, 28: 310-315.
18. Mo WC, Zhang ZJ, Liu Y, Bartlett PF, He RQ. Magnetic shielding accelerates the proliferation of human neuroblastoma cell by promoting G1-phase progression. PLoS ONE, 2013, 8: e54775.
19. Wang DL, Wang XS, Xiao R, Liu Y, He RQ. Tubulin assembly is disordered in a hypogeomagnetic field. Biochem Biophys Res Commun, 2008, 376: 363-368.
20. Martino CF, Perea H, Hopfner U, Ferguson VL, Wintermantel E. Effects of weak static magnetic fields on endothelial cells. Bioelectromagnetics, 2010, 31: 296-301.
21. Martino CF, Portelli L, McCabe K, Ferguson VL, Wintermantel E. Reduction of the Earth's magnetic field inhibits growth rates of model cancer cell lines. Bioelectromagnetics, 2010, 31: 649-655.
22. Belyaev I Ya, Alipov YD, Harms-Ringdahl M. Effects of zero magnetic field on the conformation of chromatin in human cells. Biochim Biophys Acta, 1997, 1336: 465-473.
23. Martino CF, Castello PR. Modulation of hydrogen peroxide production in cellular systems by low level magnetic fields. PLoS ONE, 2011, 6: e22753.
24. Foley LE, Gegear RJ, Reppert SM. Human cryptochrome exhibits light dependent magnetosensitivity. Nat Commun, 2011, 2: 356.
25. Maeda K, Robinson AJ, Henbest KB, Hogben HJ, Biskup T, Ahmad M, Schleicher E, Weber S, Timmel CR, Hore PJ. Magnetically sensitive light-induced reactions in cryptochrome are consistent with its proposed role as a magnetoreceptor. Proc Natl Acad Sci USA, 2012, 109: 4774-4779.
26. Xu CX, Xiao Y, Lv Y, Wu CZ, Zhang YX, Song T. A near-null magnetic field affects cryptochrome-related hypocotyl growth and flowering in Arabidopsis. AdvSpace Res, 2012, 49: 834-840.
27. Green CD, Simons JF, Taillon BE, Lewin DA. Open systems: panoramic views of gene expression. J Immunol Methods, 2001, 250: 67-79.
28. Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in genome-wide association studies. Am J Epidemiol, 2009, 169: 219-226.
29. David JP, Coissac E, Melodelima C, Poupardin R, Riaz MA, Chandor-Proust A, Reynaud S. Transcriptome response to pollutants and insecticides in the dengue vector Aedes aegypti using next-generation sequencing technology. BMC Genomics, 2010, 11: 216.
30. Zhang Y, Schulz VP, Reed BD, Wang Z, Pan X, Mariani J, Euskirchen G, Snyder MP, Vaccarino FM, Ivanova N, Weissman SM, Szekely AM. Functional genomic screen of human stem cell differentiation reveals pathways involved in neurodevelopment and neurodegeneration. Proc Natl Acad Sci USA, 2013, 110: 12361-12366.
31. Han Y, Zhang Y, Mei Y, Wang Y, Liu T, Guan Y, Tan D, Liang Y, Yang L, Yi X. Analysis of hepatitis B virus genotyping and drug resistance gene mutations based on massively parallel sequencing. J Virol Methods, 2013, 193: 341-347.
32. Ma L, Nie L, Liu J, Song S, Sun M, Yang J, Yang Y, Fang X, Hu S, Zhao Y, Yu J. An RNA-seq-based gene expression profiling of radiation-induced tumorigenic mammary epithelial cells. Genom Proteom Bioinform, 2012, 10: 326-335.
33. Morrissy AS, Morin RD, Delaney A, Zeng T, McDonald H, Jones S, Zhao Y, Hirst M, Marra MA. Next-generation tag sequencing for cancer gene expression profiling. Genome Res, 2009, 19: 1825-1835.
34. Mo WC, Liu Y, Jiang YD, Zhai GJ, He RQ. A Magnetic shielded incubation system for investigating biological effects of hypomagnetic field. Space Med Med Eng, 2013, 26: 249-253.
35. Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics, 2008, 24: 713-714.
36. Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res, 1997, 7: 986-995.
37. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist, 2001, 29: 1165-1188.
38. Hooper SD, Bork P. Medusa: a simple tool for interaction graph analysis. Bioinformatics, 2005, 21: 4432-4433.
39. Gene Ontology Consortium. The gene ontology (GO) project in 2006. Nucleic Acids Res, 2006, 34: D322-326.
40. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 2000, 25: 25-29.
41. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, Carvunis AR, Pulak R, Shingles J, Reece-Hoyes J, Hunt-Newbury R, Viveiros R, Mohler WA, Tasan M, Roth FP, Le Peuch C, Hope IA, Johnsen R, Moerman DG, Barabási AL, Baillie D, Vidal M. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol, 2007, 25: 663-668.
42. Schlitt T, Palin K, Rung J, Dietmann S, Lappe M, Ukkonen E, Brazma A. From gene networks to gene function. Genome Res, 2003, 13: 2568-2576.
43. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res, 2004, 32: D277-280.
44. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. Whole Pathway Scope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinform, 2006, 7: 30.
45. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res, 2007, 17: 1537-1545.
46. Wang X, Spandidos A, Wang H, Seed B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucl Acids Res, 2012, 40: D1144-11499.
47. Greenwald I, Kovall R. Notch signaling: genetics and structure. WormBook, 2013, 17: 1-28.
48. Boyle JJ, Johns M, Kampfer T, Nguyen AT, Game L, Schaer DJ, Mason JC, Haskard DO. Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res, 2012, 110: 20-33.
49. Huang GL, Guo HQ, Yang F, Liu OF, Li BB, Liu XY, Lu Y, He ZW. Activating transcription factor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 2012, 13: 1053-1057.
50. Jin T, Liu L. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol, 2008, 2: 2383-2392.
51. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a β-catenin-TCF complex in APC colon carcinoma. Science, 1997, 275: 1784-1787.
52. Nagano T, Hashimoto T, Nakashima A, Hisanaga S, Kikkawa U, Kamada S. Cyclin I is involved in the regulation of cell cycle progression. Cell Cycle, 2013, 12: 2617-2624.
53. Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of the G1/S transition phase in mesangial cells by E2F1. Kidney Int, 1999, 56: 1238-1241.
54. Seo WY, Jeong BC, Yu EJ, Kim HJ, Kim SH, Lim JE, Kwon GY, Lee HM, Kim JH. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2. Nucleic Acids Res, 2013, 41: 8526-8536.
55. Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell, 2008, 31: 510-519.
56. Cobb J, Miyaike M, Kikuchi A, Handel MA. Meiotic events at the centromeric heterochromatin: histone H3 phosphorylation, topoisomerase II alpha localization and chromosome condensation. Chromosoma, 1999, 108: 412-425.
57. Dovey M, Patton EE, Bowman T, North T, Goessling W, Zhou Y, Zon L. Topoisomerase II alpha is required for embryonic development and liver regeneration in zebrafish. Mol Cell Biol, 2009, 29: 3746-3753.
58. Magnaghi-Jaulin L, Ait-Si-Ali S, Harel-Bellan A. Histone acetylation and control of the cell cycle. Prog Cell Cycle Res, 2000, 4: 41-47.
59. Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P, Reinberg D. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33 (ING1). Mol Cell Biol, 2002, 22: 835-848.
60. Pile LA, Schlag EM, Wassarman DA. The SIN3/RPD3 deacetylase complex is essential for G(2) phase cell cycle progression and regulation of SMRTER corepressor levels. Mol Cell Biol, 2002, 22: 4965-4976.
61. Gui JF, Lane WS, Fu XD. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature, 1994, 369: 678-682.
62. Tanner S, Stagljar I, Georgiev O, Schaffner W, Bourquin JP. A novel SR-related protein specifically interacts with the carboxy-terminal domain (CTD) of RNA polymerase II through a conserved interaction domain. Biol Chem, 1997, 378: 565-571.
63. Padrick SB, Rosen MK. Physical mechanisms of signal integration by WASP family proteins. Annu Rev Biochem, 2010, 79: 707-735.
64. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol, 2010, 11: 276-287.
65. Gartzke J, Lange K. Cellular target of weak magnetic fields: ionic conduction along actin filaments of microvilli. Am J Physiol Cell Physiol, 2002, 283: C1333-1346.
66. Lepesheva GI, Waterman MR. CYP51-the omnipotent P450. Mol Cell Endocrinol, 2004, 215: 165-170.
67. Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol, 2008, 21: 70-83.
68. Thangavel R, Stolmeier D, Yang X, Anantharam P, Zaheer A. Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease. Neuropathol Appl Neurobiol, 2012, 38: 572-581.
69. Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J. Nature and nurture in suicidal behavior, the role of genetics: some novel findings concerning personality traits and neural conduction. Physiol Behav, 2007, 92: 245-249.
70. Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry, 2008, 13: 131-146.
71. Rebhun JF, Castro AF, Quilliam LA. Identification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. Regulation of MR-GEF by M-Ras-GTP interaction. J Biol Chem, 2000, 275: 34901-34908.
72. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J, 1995, 9: 726-735.
73. Watanabe I, Okada S. Stationary phase of cultured mammalian cells (L5178Y). J Cell Biol, 1967, 35: 285-294.
74. Cermakian N, Pando MP, Thompson CL, Pinchak AB, Selby CP, Gutierrez L, Wells DE, Cahill GM, Sancar A, Sassone-Corsi P. Light induction of a vertebrate clock gene involves signaling through blue-light receptors and MAP kinases. Curr Biol, 2002, 12: 844-848.
75. Czarna A, Berndt A, Singh HR, Grudziecki A, Ladurner AG, Timinszky G, Kramer A, Wolf E. Structures of Drosophila cryptochrome and mouse cryptochrome 1 provide insight into circadian function. Cell, 2013, 153: 1394-1405.
76. Destici E, Oklejewicz M, Saito S, van der Horst GT. Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner. Cell Cycle, 2011, 10: 3788-3797.
77. Martínez MA, Úbeda A, Cid MA, Trillo MÁ. The proliferative response of NB69 human neuroblastoma cells to a 50 Hz magnetic field is mediated by ERK1/2 signaling. Cell Physiol Biochem, 2012, 29: 675-686.
78. Sheikh AQ, Taghian T, Hemingway B, Cho H, Kogan AB, Narmoneva DA. Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field. J R Soc Interface, 2013, 10: 20120548.